DocGo Inc. (NASDAQ:DCGO) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its position in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 199.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 328,796 shares of the company's stock after purchasing an additional 218,941 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.32% of DocGo worth $1,394,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Prudential Financial Inc. purchased a new position in shares of DocGo during the fourth quarter worth approximately $55,000. Royce & Associates LP purchased a new position in shares of DocGo during the fourth quarter worth about $64,000. Intech Investment Management LLC increased its position in DocGo by 76.7% in the 4th quarter. Intech Investment Management LLC now owns 32,834 shares of the company's stock valued at $139,000 after acquiring an additional 14,247 shares during the period. SG Americas Securities LLC raised its stake in DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock valued at $183,000 after acquiring an additional 4,905 shares during the last quarter. Finally, EntryPoint Capital LLC acquired a new stake in DocGo during the 4th quarter worth approximately $203,000. Institutional investors and hedge funds own 56.44% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on DCGO. Needham & Company LLC reaffirmed a "buy" rating and issued a $4.00 price objective on shares of DocGo in a report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and cut their price objective for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Finally, Stifel Nicolaus decreased their target price on shares of DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $4.89.

DocGo Trading Up 0.7 %

Shares of DocGo stock traded up $0.02 during mid-day trading on Thursday, hitting $2.25. 67,009 shares of the stock were exchanged, compared to its average volume of 740,871. The stock has a market capitalization of $228.95 million, a price-to-earnings ratio of 8.02, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. DocGo Inc. has a twelve month low of $2.02 and a twelve month high of $5.68. The company has a 50-day simple moving average of $2.72 and a 200 day simple moving average of $3.74.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.